Mongkolpathumrat, P., Kijtawornrat, A., Prompunt, E., Panya, A., Chattipakorn, N., Barrère-Lemaire, S., & Kumphune, S. (2021). Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury. Biomedicines.

Mongkolpathumrat, Podsawee, Anusak Kijtawornrat, Eakkapote Prompunt, Aussara Panya, Nipon Chattipakorn, Stephanie Barrère-Lemaire, und Sarawut Kumphune. "Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury." Biomedicines 2021.

Mongkolpathumrat, Podsawee, et al. "Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury." Biomedicines 2021.